
Results
2
2 companies
Hyloris Pharmaceuticals
Market Cap: €157.4m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.62
7D
-6.3%
1Y
-16.6%
argenx
Market Cap: €36.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€584.80
7D
-4.7%
1Y
2.8%